Friess Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,124
Closed -$81K 119
2016
Q4
$81K Sell
1,124
-711
-39% -$51.4K 0.01% 131
2016
Q3
$143K Hold
1,835
0.01% 125
2016
Q2
$143K Hold
1,835
0.01% 121
2016
Q1
$150K Hold
1,835
0.02% 119
2015
Q4
$164K Hold
1,835
0.02% 111
2015
Q3
$141K Hold
1,835
0.01% 121
2015
Q2
$153K Sell
1,835
-166,000
-99% -$14.7M 0.01% 115
2015
Q1
$15.2M Sell
167,835
-5,925
-3% -$510K 1.23% 41
2014
Q4
$14M Buy
173,760
+171,925
+9,369% +$13.6M 1.13% 38
2014
Q3
$137K Hold
1,835
0.01% 112
2014
Q2
$126K Sell
1,835
-397,065
-100% -$27M 0.01% 122
2014
Q1
$27.9M Sell
398,900
-2,900
-0.7% -$202K 2.19% 7
2013
Q4
$26.8M Buy
401,800
+394,140
+5,145% +$24.1M 2.02% 14
2013
Q3
$399K Sell
7,660
-769,755
-99% -$39.1M 0.03% 84
2013
Q2
$36.7M Buy
+777,415
New +$35.5M 2.88% 3

Other funds holding CAH

Friess Associates's CAH Position: Q1 2017 in Review

Friess Associates sold out of Cardinal Health (CAH) in Q1 2017, closing a stake of 1,124 shares — an estimated $81K sold.

Friess Associates first reported a position in CAH in Q2 2013 and held it in 15 quarters. The position peaked at $36.7M in Q2 2013. 767 funds tracked by Wall St. Rank hold CAH as of Q1 2017.

  • Friess Associates reported no remaining Cardinal Health position as of Q1 2017 after selling out during the quarter.
  • Friess Associates sold 1,124 Cardinal Health shares in Q1 2017, an estimated $81K.
  • Friess Associates first reported a position in Cardinal Health in Q2 2013 and held it in 15 quarters.
  • Friess Associates's Cardinal Health position peaked at $36.7M in Q2 2013.
  • 767 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2017.

Based on Friess Associates's 13F filing for Q1 2017, filed 15 May 2017.